未登录 Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program 评估年龄对溃疡性结肠炎患者中Etrasimod安全性和有效性的影响：ELEVATE UC临床项目数据的回顾性分析 Lichtenstein, Gary R.; Allegretti, Jessica R.; Loftus Jr, Edward, V; Irving, Peter M.; Banerjee, Rupa; Charabaty, Aline; Kuehbacher, Tanja; Bananis, Eustratios; Woolcott, John C.; Dalam, Alexis B.; Lazin, Krisztina; Keating, Michael; Mcdonnell, Aoibhinn; Danese, Silvio 分享 收藏
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis 溃疡性结肠炎患者同时使用Etrasimod与阿片类药物或抗抑郁药-安全性分析 Afzali, Anita; Regueiro, Miguel; Yarur, Andres J.; Zabana, Yamile; Ng, Siew C.; Menon, Sujatha; Mcdonnell, Aoibhinn; Lazin, Krisztina; Keating, Michael; Bhattacharjee, Abhishek; Branquinho, Diogo; Bananis, Eustratios; Peyrin-Biroulet, Laurent 分享 收藏
P1183 Multivariable analysis of baseline variables associated with efficacy outcomes in the ELEVATE UC clinical programme Feagan, B. G.; Kayal, M.; Schreiber, S.; Abreu, M. T.; Banerjee, R.; Fellmann, M.; Abbatemarco, A. M.; Woolcott, J. C.; Wu, J.; Goetsch, M.; Keating, M.; Rubin, D. T. 分享 收藏
Efficacy and safety of etrasimod in Japanese UC patients: results of a phase 2 dose-ranging study Takeuchi, K.; Nakase, H.; Hisamatsu, T.; Matsuoka, K.; Arai, S.; Yuasa, H.; Oe, M.; Ono, R.; Keating, M.; Gu, G.; Lazin, K.; Mcdonnell, A.; Fokuta, K.; Hibi, T. 分享 收藏
Etrasimod efficacy in patients with mildly to moderately active Ulcerative Colitis (modified Mayo score 4-6) in the phase 3 ELEVATE UC clinical programme Yarur, A. J.; D'Haens, G. R.; Baert, F.; Goetsch, M.; Zang, C.; Gu, G.; Mazur, R.; Keating, M.; Kudlacz, E.; Sidhu, S.; Wosik, K.; Danese, S. 分享 收藏
Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials Lees, Charlie W.; Torres, Joana; Leung, Yvette; Vermeire, Severine; Fellmann, Marc; Modesto, Irene; Mcdonnell, Aoibhinn; Lazin, Krisztina; Keating, Michael; Goetsch, Martina; Wu, Joseph; Loftus Jr, Edward V. 分享 收藏
分享 收藏
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials Vermeire, Severine; Sands, Bruce E.; Peyrin-Biroulet, Laurent; D'Haens, Geert R.; Panes, Julian; Yarur, Andres J.; Wolf, Douglas C.; Ritter, Timothy; Schreiber, Stefan; Woolcott, John C.; Modesto, Irene; Keating, Michael; Shan, Kevin; Wu, Joseph; Chiorean, Michael, V; Baert, Filip; Dubinsky, Marla C.; Goetsch, Martina; Danese, Silvio; Feagan, Brian G. 分享 收藏
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme Peyrin-Biroulet, Laurent; Dubinsky, Marla C.; Sands, Bruce E.; Panes, Julian; Schreiber, Stefan; Reinisch, Walter; Feagan, Brian G.; Danese, Silvio; Yarur, Andres J.; D'Haens, Geert R.; Goetsch, Martina; Wosik, Karolina; Keating, Michael; Lazin, Krisztina; Wu, Joseph; Modesto, Irene; McDonnell, Aoibhinn; Bartolome, Lauren; Vermeire, Severine 分享 收藏
分享 收藏
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL nivolumab联合依鲁替尼治疗CLL弥漫性大b细胞里氏转化患者的2期研究 Jain, Nitin; Senapati, Jayastu; Thakral, Beenu; Ferrajoli, Alessandra; Thompson, Philip; Burger, Jan; Basu, Sreyashi; Kadia, Tapan; Daver, Naval; Borthakur, Gautam; Konopleva, Marina; Pemmaraju, Naveen; Parry, Erin; Wu, Catherine J.; Khoury, Joseph; Bueso-Ramos, Carlos; Garg, Naveen; Wang, Xuemei; Lopez, Wanda; Ayala, Ana; O'Brien, Susan; Kantarjian, Hagop; Keating, Michael; Allison, James; Sharma, Padmane; Wierda, William 分享 收藏
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD Thompson, Philip A. A.; Keating, Michael J. J.; Ferrajoli, Alessandra; Jain, Nitin; Peterson, Christine B. B.; Garg, Naveen; Wang, Sa A. A.; Jorgensen, Jeffrey L. L.; Kadia, Tapan M. M.; Bose, Prithviraj; Pemmaraju, Naveen; Short, Nicholas J. J.; Wierda, William G. G. 分享 收藏
Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity Gordon, Max J.; Jones, Jade E.; George, Binsah; Peterson, Christine; Burger, Jan A.; Jain, Nitin; Keating, Michael; Wierda, William G.; Durand, Jean-Bernard; Ferrajoli, Alessandra 分享 收藏
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies Boddu, Prajwal C.; Senapati, Jayastu; Ravandi-Kashani, Farhad; Jabbour, Elias J.; Jain, Nitin; Ayres, Mary; Chen, Yuling; Keating, Michael J.; Kantarjian, Hagop M.; Gandhi, Varsha; Kadia, Tapan M. 分享 收藏
A phase two study of high dose blinatumomab in Richter's syndrome Thompson, Philip A.; Jiang, Xianli; Banerjee, Pinaki; Basar, Rafet; Garg, Naveen; Chen, Ken; Kaplan, Mecit; Nandivada, Vandana; Cortes, Ana Karen Nunez; Ferrajoli, Alessandra; Keating, Michael J.; Peterson, Christine B.; Andreeff, Michael; Rezvani, Katayoun; Wierda, William G. 分享 收藏
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells Rozovski, Uri; Veletic, Ivo; Harris, David M.; Li, Ping; Liu, Zhiming; Jain, Preetesh; Manshouri, Taghi; Ferrajoli, Alessandra; Burger, Jan A.; Bose, Prithviraj; Thompson, Phillip A.; Jain, Nitin; Wierda, William G.; Verstovsek, Srdan; Keating, Michael J.; Estrov, Zeev 分享 收藏
TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis Cherng, Hua-Jay J.; Khwaja, Raamis; Kanagal-Shamanna, Rashmi; Tang, Guilin; Burger, Jan; Thompson, Philip; Ferrajoli, Alessandra; Estrov, Zeev; Sasaki, Koji; Sampath, Deepa; Wang, Xuemei; Kantarjian, Hagop; Keating, Michael; Wierda, William G.; Jain, Nitin 分享 收藏
分享 收藏
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations Jain, Nitin; Thompson, Philip; Burger, Jan; Ferrajoli, Alessandra; Takahashi, Koichi; Estrov, Zeev; Borthakur, Gautam; Bose, Prithviraj; Kadia, Tapan; Pemmaraju, Naveen; Sasaki, Koji; Konopleva, Marina; Jabbour, Elias; Garg, Naveen; Wang, Xuemei; Kanagal-Shamanna, Rashmi; Patel, Keyur; Wang, Wei; Jorgensen, Jeffrey; Wang, Sa; Lopez, Wanda; Ayala, Ana; Plunkett, William; Gandhi, Varsha; Kantarjian, Hagop; O'Brien, Susan; Keating, Michael; Wierda, William G. 分享 收藏
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action Chen, Rong; Tsai, Jennifer; Thompson, Philip A.; Chen, Yuling; Xiong, Ping; Liu, Chaomei; Burrows, Francis; Sivina, Mariela; Burger, Jan A.; Keating, Michael J.; Wierda, William G.; Plunkett, William 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
